ONO-4538 Phase III Study A Multicenter, Randomized, Open-label Study in Patients With Esophageal Cancer Refractory or Intolerant to Combination Therapy With Fluoropyrimidine and Platinum-based Drugs
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00009925/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of study is to evaluate the efficacy and safety of Nivolumab in unresectable
advanced or recurrent esophageal cancer patients who have failed in standard chemotherapies.
提供机构：
Vivli
创建时间：
2024-04-01
